FDA Inspection 1004463 — King Bio Inc.

King Bio Inc. — FEI 1053442

The FDA completed an inspection of King Bio Inc. on March 2, 2017 in Asheville, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 2, 2017
Fiscal Year
2017
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Asheville, NC (United States)